- Home
- ARES vs DXCM Comparison
ARES vs DXCM Comparison
Compare ARES & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARES
- DXCM
- Stock Information
- Founded
- ARES 1997
- DXCM 1999
- Country
- ARES United States
- DXCM United States
- Employees
- ARES N/A
- DXCM N/A
- Industry
- ARES Investment Managers
- DXCM Medical/Dental Instruments
- Sector
- ARES Finance
- DXCM Health Care
- Exchange
- ARES Nasdaq
- DXCM Nasdaq
- Market Cap
- ARES 37.1B
- DXCM 34.1B
- IPO Year
- ARES 2014
- DXCM 2005
- Fundamental
- Price
- ARES $182.66
- DXCM $79.28
- Analyst Decision
- ARES Buy
- DXCM Strong Buy
- Analyst Count
- ARES 13
- DXCM 19
- Target Price
- ARES $180.50
- DXCM $99.89
- AVG Volume (30 Days)
- ARES 1.3M
- DXCM 3.1M
- Earning Date
- ARES 08-01-2025
- DXCM 07-30-2025
- Dividend Yield
- ARES 2.45%
- DXCM N/A
- EPS Growth
- ARES N/A
- DXCM N/A
- EPS
- ARES 1.76
- DXCM 1.43
- Revenue
- ARES $4,266,223,000.00
- DXCM $4,300,800,000.00
- Revenue This Year
- ARES $17.20
- DXCM $16.74
- Revenue Next Year
- ARES $24.20
- DXCM $15.42
- P/E Ratio
- ARES $104.01
- DXCM $55.44
- Revenue Growth
- ARES 21.00
- DXCM 9.30
- 52 Week Low
- ARES $110.63
- DXCM $57.52
- 52 Week High
- ARES $200.49
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- ARES 55.52
- DXCM 35.30
- Support Level
- ARES $175.40
- DXCM $83.23
- Resistance Level
- ARES $190.08
- DXCM $89.98
- Average True Range (ATR)
- ARES 4.64
- DXCM 1.91
- MACD
- ARES -0.05
- DXCM -0.54
- Stochastic Oscillator
- ARES 54.70
- DXCM 3.17
About ARES Ares Management Corporation
Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.